Risk of thrombosis and major bleeding in JAK2-positive myeloproliferative neoplasm patients receiving low-dose aspirin: a systematic review and meta-analysis

Notice brève
dc.contributor.authorKimpton, Miriam
dc.contributor.authorDelluc, Aurelien
dc.contributor.authorFergusson, Dean
dc.contributor.authorCarrier, Marc
dc.date.accessioned2020-02-24T22:45:56Z
dc.date.available2020-02-24T22:45:56Z
dc.date.issued2020
dc.description.abstractProtocol for a systematic review and meta-analysisen_US
dc.identifier.urihttp://hdl.handle.net/10393/40206
dc.identifier.urihttps://doi.org/10.20381/ruor-24439
dc.language.isoenen_US
dc.subjectMyeloproliferative Neoplasmsen_US
dc.subjectAspirinen_US
dc.titleRisk of thrombosis and major bleeding in JAK2-positive myeloproliferative neoplasm patients receiving low-dose aspirin: a systematic review and meta-analysisen_US
dc.typeOtheren_US

Fichiers

Trousse originale

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
Systematic Review Protocol.docx
Taille:
53.47 KB
Format:
Microsoft Word XML
Description:
Systematic Review Protocol
Télécharger

Trousse de licence

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
license.txt
Taille:
4.92 KB
Format:
Item-specific license agreed upon to submission
Description:
Télécharger

Collections

Épidémiologie et santé publique // Epidemiology and Public Health